- Poster presentation
- Open Access
Cognitive disorders in 6-hydroxydopamine-induced rat model of Parkinson's disease
© Hritcu et al.; licensee BioMed Central Ltd. 2008
- Published: 17 April 2008
- Substantia Nigra
- Ventral Tegmental Area
- Memory Process
- Cognitive Disorder
Parkinson's disease is a human neurodegenerative disorder which is mainly characterized by a massive and progressive degeneration of the dopaminergic neurons in the substantia nigra (SN). The most widely used animal models of Parkinson's disease involve intracranial infusion of the neurotoxin 6-hydroxydopamine (6-OHDA) directly into the ascending dopaminergic forebrain bundle, thereby, inducing severe dopaminergic neuronal degeneration associated with profound deficits in feeding, drinking, sensorimotor and learning functions [1–4]. The aim of the present work was to study the effects of right-unilateral 6-OHDA lesions of the ventral tegmental area (VTA) or substantia nigra pars reticulata (SNr) on learning and memory processes evidenced by means of Y-maze task and shuttle-box task, respectively. We also examined the effect of nicotine treatment on the 6-OHDA lesioned rats. Our data suggest that a correlation exist between VTA, SNr and nAchRS and expression of cognitive capacities.
Male Wistar rats were subjected to right-unilateral 6-hydroxydopamine (6-OHDA) (8µg/4µl) lesions of the ventral tegmental area (VTA) or substantia nigra pars reticulata (SNr), or were sham lesioned, and nicotine treatment and their ability to acquire the operant task was studied by means of Y-maze task and shuttle-box task, respectively. For the lesioning of the SN the following coordinates were used: 5.5 mm.
Posterior to bregma; 2.0 mm lateral to the midline; 7.4 mm ventral to the surface of the cortex. For lesioning the VTA, the following coordinates were used: 5.6 mm.
Posterior to bregma; 0.5 mm lateral to the midline; 7.6 mm ventral to the surface of the cortex. The sham-operated rats were injected with saline. Learning and memory tests were began 2 weeks after the operation.
Lesions of both VTA and SNr resulted in an impairment of both conditioned avoidance response and crossing latency tested by means of shuttle-box task, suggesting significant effects of long-term memory. 6-OHDA significantly decreased spontaneous alternation in Y-maze task, suggesting effects on spatial memory, especially on short-term memory. A low dose of nicotine (0.3 mg/kg b.w., i.p.), a specific nicotinic acetylcholine receptors (nAchRS), administrated 4 consecutively days attenuated the impairment of learning and memory processes in 6-OHDA lesioned rats.
These data suggest that VTA, SN and nAchRS have a facilitator role in learning and memory processes. Therefore, the integrity of these nervous areas may be necessary for processing and storage of information.
This research was supported by the National Council of Scientific Research and University Education (CNCSIS), Grant A, no. 639, Romania.
- Kitayama T, Onitsuka Y, Song L, Morioka N, Morita K, Dohi T: Assessing an eating disorder induced by 6-OHDA and the possibility of nerve regeneration therapy by transplantation of neural progenitor cells in rats. Nihon Shinkei Seishin Yakurigaku Zasshi. 2007, 27 (3): 109-16.PubMedGoogle Scholar
- Fitzsimmons DF, Moloney TC, Dowd E: Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism. Behav Brain Res. 2006, 15:169 (2): 352-355. 10.1016/j.bbr.2006.01.013.View ArticleGoogle Scholar
- Shimura T, Kamada Y, Yamamoto T: Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats. Behav Brain Res. 2002, 134 (1-2): 123-130. 10.1016/S0166-4328(01)00461-2.View ArticlePubMedGoogle Scholar
- Hefco V, Yamada K, Hefco A, Hritcu L, Tiron A, Nabeshima T: Role of the mesotelencephalic dopamine system in learning and memory processes in the rat. Eur J Pharmacol. 2003, 15;475 (1-3): 55-60. 10.1016/S0014-2999(03)02115-0.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd.